Metraipolis › archive › dc_cb6d16f5d5fd

Advancing precision cardio-oncology: multimodal surveillance and stratified management of immunotherapy-induced cardiovascular toxicity — Europe PMC PMID:42828050

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42828050
DOI
10.3389/fcvm.2026.1891563
License (as archived)
solo-consultazione
Archived
2026-10-08T06:09:53.486Z
SHA-256 of the archived text
fec4824192d6f6c050dae34255e5dca1e15a812068e2442f038883e1d09734ac
Stable URL of this page
https://metraipolis.com/documento/dc_cb6d16f5d5fd

How to cite

Advancing precision cardio-oncology: multimodal surveillance and stratified management of immunotherapy-induced cardiovascular toxicity — Europe PMC PMID:42828050 — Europe PMC (en), https://europepmc.org/article/MED/42828050 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cb6d16f5d5fd (Metraipolis archive dc_cb6d16f5d5fd, sha256 fec4824192d6f6c050dae34255e5dca1e15a812068e2442f038883e1d09734ac)
BibTeX
@misc{dccb6d16f5d5fd,
  title = {Advancing precision cardio-oncology: multimodal surveillance and stratified management of immunotherapy-induced cardiovascular toxicity — Europe PMC PMID:42828050},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42828050},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cb6d16f5d5fd; sha256 fec4824192d6f6c050dae34255e5dca1e15a812068e2442f038883e1d09734ac},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42828050. Agents can read the archived copy with the MCP tool read_document.